ImmuCell Corporation ( ICCC) - Stock Earnings
ICCC Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 12, 2026, midnight | — / — | — | — / — | — |
ICCC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -2.8 million USD | 7.6 million USD |
| 2026Q1 | 1.9 million USD | 10.4 million USD |
| 2026Q2 | 1.8 million USD | 7.2 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ICCC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -5.8 million USD | 17.5 million USD |
| 2024 | -2.2 million USD | 26.5 million USD |
| 2025 | -1.0 million USD | 27.6 million USD |
| 2026 Est. | — | — |
ICCC
Price: $10.75
Earnings Per Share: 0.07 USD
P/E Ratio: 144.71
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8519
Ebitda: 1.2 millionMarket Capitalization: 88.2 million